SP Elixir (OPC) Private Limited

Bortenat 2mg Bortezomib injection is a medication primarily used in the treatment of multiple myeloma (a type of blood cancer) and mantle cell lymphoma. Bortezomib, the active ingredient, works by inhibiting the proteasome, an enzyme responsible for degrading proteins within cells. This inhibition leads to the accumulation of damaged proteins, which induces cell death, especially in cancer cells that are rapidly dividing.

Bortenat 2mg is typically administered intravenously or subcutaneously (under the skin) by a healthcare provider, following specific dosing schedules based on the condition being treated. The drug is often used in combination with other chemotherapy drugs, depending on the treatment plan.

Common side effects can include:

• Fatigue
• Nausea
• Diarrhea
• Low blood cell counts (leading to increased risk of infection, anemia, or bleeding)
• Peripheral neuropathy (nerve damage, causing tingling or pain in hands and feet)

Before starting treatment with Bortenat, your doctor will evaluate your overall health and discuss the potential risks and benefits of the medication. It's essential to follow the doctor's instructions closely and attend regular follow-up appointments to monitor the drug's effects.

Would you like more detailed information about the drug or its side effects?